Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe
Detects two independent SARS-CoV-2 viral RNA targets from respiratory samples for increased confidence Differentiates SARS-CoV-2 from four other endemic human coronaviruses for specificity Validated with Bruker-Hain GenoXtract® NA and GenoXtract® 96 X3 nucleic acid extraction system and kits Validated with novel Bruker-Hain FluoroCycler® XT real-time PCR thermocycler NEHREN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today... Read more